Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Tenet Healthcare Q3 2026 Results: Net Income $1.22B, Up 110.5% YoY

Tenet Healthcare reported a significant increase in net income to $3.17 billion for the nine months ended September 30, 2026, driven largely by $1.47 billion in revenue from contract terminations. The company also completed the redemption of Catholic Health Initiatives' minority interest in Conifer Health Solutions, resulting in Conifer becoming a wholly owned subsidiary.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue5,631.05,289.0
Net income1,219.0579.0
EPS (diluted, $ a share)$12.41$3.86

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+110.5%
Revenue, year on year+6.5%
Operating margin31.1%
Source

10-Q filed with the SEC, NYSE: THC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Tenet Healthcare Corp: key numbers

Share price
$291.54Close, Nov 16
Market cap
$23.2B
Shares outstanding
79.59MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-General Medical & Surgical Hospitals, NECSIC 8062

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Tenet Healthcare Corp

All →
8:00 PM ET Form 4
Insider Selling

Tenet Healthcare Director Roy Blunt Sells $293K of Stock

Roy Blunt, Director, sold 1,000 shares of Tenet Healthcare Corp at $293.00 a share, worth $293K in total on Nov 11, 2026. Shares held after the trade: 3,589 (-21.8%).

Value
$293K
Shares
1,000
Price
$293.00
Role
Director
Holding change
-21.8%
Trade date
Nov 11, 2026
6:49 AM ET 8-K
Financial Results

Tenet Healthcare Financial Results

Tenet Healthcare reported strong Q3 2026 results with net operating revenues of $5.63 billion and Adjusted EBITDA of $1.36 billion, driven by same-store revenue growth and expense management. The company raised its full-year 2026 Adjusted EBITDA outlook to a range of $5.05 billion to $5.20 billion.

Term
Q3 2026

“Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management. Our focus on patient-centered care, support for physician partners, technology-enabled growth and operating initiatives continue to deliver strong margins and free cash flow.”

Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet
4:07 PM ET 8-K
Loan & Debt

Tenet Healthcare $2B Debt Financing with The Bank of New York Mellon Trust Company, N.A.

Tenet Healthcare Corporation issued $2.0 billion in 6.250% senior notes due 2034. The company intends to use the proceeds to redeem $1.5 billion of its 5.125% senior secured first lien notes due 2027 and $0.5 billion of its 6.125% senior notes due 2028.

Value
$2B
Counterparty
The Bank of New York Mellon Trust Company, N.A.
Term
through 2034
8:00 PM ET Form 4
Insider Selling

Tenet Healthcare Director J. Robert Kerrey Sells $3.17M of Stock

J. Robert Kerrey, Director, sold 12,010 shares of Tenet Healthcare Corp at $263.04 to $264.62 a share (average $263.72) in 3 transactions, worth $3.17M in total on Sep 14, 2026. Shares held after the trade: 4,794 (-34.3%).

Value
$3.17M
Shares
12,010
Average price
$263.72
Role
Director
Holding change
-34.3%
Trade date
Sep 14, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.